We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00742690
Recruitment Status : Unknown
Verified October 2014 by University of Padova.
Recruitment status was:  Recruiting
First Posted : August 28, 2008
Last Update Posted : October 15, 2014
Information provided by:
University of Padova